Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

76.52EUR
21 Sep 2018
Change (% chg)

€0.70 (+0.92%)
Prev Close
€75.82
Open
€76.77
Day's High
€76.99
Day's Low
€75.73
Volume
8,610,344
Avg. Vol
3,753,560
52-wk High
€118.04
52-wk Low
€69.40

Select another date:

Fri, Sep 21 2018

Bayer hemophilia treatment wins thumbs-up from EU panel

Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.

Bayer hemophilia treatment wins thumbs-up from EU panel

Sept 21 Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Factbox: Bayer's Monsanto faces broad U.S. glyphosate litigation

Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the company's glyphosate-based weed-killers, including the widely-used Roundup brand, caused his cancer.

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Sept 18 Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Bayer says agriculture trade flows may change amid tariffs dispute

MONHEIM, Germany, Sept 18 Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities.

Exclusive: Bayer puts stake in chemical park operator up for sale - sources

FRANKFURT Bayer is inviting financial investors to bid for its 60 percent stake in chemical park operator Currenta after initially failing to agree a sale to its former chemicals subsidiary Covestro, three people familiar with the matter told Reuters.

Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will join Sanofi to stem a decline in prices in the French drugmaker's anti-diabetics and established drugs.

UPDATE 1-Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT, Sept 13 Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will join Sanofi to stem a decline in prices in the French drugmaker's anti-diabetics and established drugs.

Select another date: